FDA Issues Warning Letter To South Korean Drug Manufacturer Over Sterility Concerns
The FDA sent a warning letter to a South Korean drug manufacturer threatening to ban its products for the second time this year over manufacturing deficiencies.
The FDA sent a warning letter to a South Korean drug manufacturer threatening to ban its products for the second time this year over manufacturing deficiencies.